Citeline Podcasts

HBW Insight catches up with our own US Executive Editor, Malcolm Spicer, to find out all about Perrigo subsidiary HRA Pharma’s Rx-to-OTC switch of its daily contraceptive, Opill. Currently under consideration by the US Food and Drug Administration after a positive recommendation from its advisory committees, Spicer draws on 30+ years of writing about the US consumer healthcare market, as well as his extensive coverage of the subject, to tell us all we need to know about this historic switch.

Quick Listen: Scrip's Five Must-Know Things

https://scrip.pharmaintelligence.informa.com/SC148417/Quick-Listen-Scrips-Five-MustKnow-Things

Brian Yang and Dexter Yan discuss the latest China biotech trends and topics including recent mega-million deals between domestic biotechs and MNCs, the inaugural Asia Bio Partnering Forum and drug makers’ creative ways to financing amid lingering “capital winter”, and GLP-1 receptor agonists stepping into the spotlight and its potential to become the next hot pursuit after PD-1 in China.

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb discusses how two medtech CEOs are and aren’t using ChatGPT in their businesses while Reed Miller talks about his “Cardio Conversations” podcast interviews with Quentin Blackford, CEO of iRhythm and Rob Krummen, CEO of Vektor Medical. Washington, DC-based reporter Hannah Daniel reviews highlights from the HIMSS conference and the latest updates on FDA guidances.

Listen to the podcast via the player below:

Medtech Insight articles addressing topics discussed in this episode:

Cardio Conversations: iRhythm Prepares To Deliver ‘Standard-Of-Care’ Cardiac Monitoring

Cardio Conversations: Vektor Addresses ‘Global Health Crisis’ With Arrythmia Mapping

HIMSS23

Using The Metaverse To Break Down Language Barriers and Improve Diversity In Clinical Trials

Tales From HIMSS23: FDA On FHIR And AI For The Voiceless

Decentralized Clinical Trial Guidance Fulfills Promise, Underlies Digitization Of Healthcare

Expert: FDA’s Highly Anticipated PCCP Guidance Isn’t Anything Too ‘Surprising’

How Two Medtech CEOs Are (And Aren’t) Using ChatGPT In Their Businesses

Quick Listen: Scrip's Five Must-Know Things:

https://scrip.pharmaintelligence.informa.com/SC148375/Quick-Listen-Scrips-Five-MustKnow-Things

Quentin Blackford, CEO of iRhythm, talked to Medtech Insight about his company’s plans to bring its Zio long-term cardiac monitoring platform to more patients by building its evidence base and marketing in more countries outside the US.

For more information on iRhythm, cardiac monitoring and ECG technologies, check out these articles at Medtech Insight.

Cardio Conversations: Vektor Addresses ‘Global Health Crisis’ With Arrythmia Mapping

https://medtech.pharmaintelligence.informa.com/MT147825/Cardio-Conversations-Vektor-Addresses-Global-Health-Crisis-With-Arrythmia-Mapping

CMS Proposes National Payments For Long-Term Continuous Electrocardiogram Monitoring

https://medtech.pharmaintelligence.informa.com/MT145597/CMS-Proposes-National-Payments-For-Long-Term-Continuous-Electrocardiogram-Monitoring

FDA Clears iRhythm’s Afib-Detecting Wearable Running Software Co-Developed By Verily

https://medtech.pharmaintelligence.informa.com/MT145646/FDA-Clears-iRhythms-Afib-Detecting-Wearable-Running-Software-Co-Developed-By-Verily

Exec Chat: As Reimbursement Questions Get Answers, iRhythm Looks To The Future

https://medtech.pharmaintelligence.informa.com/MT145401/Exec-Chat-As-Reimbursement-Questions-Get-Answers-iRhythm-Looks-To-The-Future

JPM 2022: Abbott, iRhythm, Novocure, Zimmer Biomet

https://medtech.pharmaintelligence.informa.com/MT144935/JPM-2022-Abbott-iRhythm-Novocure-Zimmer-Biomet

Exec Chat: New iRhythm CEO Foresees Enormous Opportunity In AI For Arrhythmia Detection

https://medtech.pharmaintelligence.informa.com/MT144913/Exec-Chat-New-iRhythm-CEO-Foresees-Enormous-Opportunity-In-AI-For-Arrhythmia-Detection

Dexcom COO Quentin Blackford Takes CEO Job At iRhythm

https://medtech.pharmaintelligence.informa.com/MT144461/Dexcom-COO-Quentin-Blackford-Takes-CEO-Job-At-iRhythm

스크립의 박재홍 동아ST R&D 총괄 부문 사장 인터뷰 기사를 요약한 내용입니다

https://scrip.pharmaintelligence.informa.com/SC148059/Dong-A-ST-Faces-New-Wave-Of-Change-As-It-Challenges-Norms

In this episode, HBW Insight speaks to the Global Self-Care Federation’s director of regulatory and scientific affairs, Padmaja Kamath, about the organisation’s sustainability work. In 2019, GSCF published its Global Charter for Environmental Sustainability, which represented, Kamath notes, the global consumer healthcare industry’s “first commitment to drive sustainable self-care.” Kamath updates us on the progress of the charter, which calls on GSCF members to pledge to make progress on one or more of three key sustainability areas: plastics and packaging, pharmaceuticals in the environment and CO2 footprint. We dive a little deeper into some specific challenges within these areas, such as recyclable blister packs and supply chain emissions, with Kamath pointing also to an upcoming GSCF webinar on the latter.

Quick Listen: Scrip's Five Must-Know Things:

https://scrip.pharmaintelligence.informa.com/SC148335/Quick-Listen-Scrips-Five-MustKnow-Things

Scrip senior writer Joseph Haas overviews biopharma deal-making in 2022 and discusses the Pfizer/Seagen merger and what that may mean for pharma M&A during the remainder of 2023, with EF Hutton analyst Mike King and Mintz attorney Matt Gardella.